Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Primary central nervous system lymphoma: an update
Current Opinion in Oncology, 10/12/09
Soussain C et al. – The standard of care for PCNSL has definitively switched toward a curative objective. Considerable cooperative efforts are being made and will hopefully result in both a better understanding of the disease and significant therapeutic outcomes.
Related Articles
Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy
Annals of Oncology, 10/30/09
Relevance Score: 81%
When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type
Annals of Oncology, 10/29/09
Relevance Score: 80%
Primary central nervous system lymphoma
Current Opinion in Neurology, 11/11/09
Relevance Score: 79%
Treatment options for central nervous system lymphomas in immunocompetent patients
Expert Review of Neurotherapeutics, 10/23/09
Relevance Score: 79%
Concurrent Renal Cell Carcinoma and Central Nervous System Lymphoma in a Patient with Autosomal Dominant Polycystic Kidney Disease
Medical Principles and Practice, 10/06/09
Relevance Score: 78%
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations
British Journal of Haematology, 11/20/09
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression
Molecular Cancer, 11/20/09
Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines
Molecular Cancer, 11/20/09
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Human neuroblastoma cell line SNU-NB1 loses sensitivity to brain-derived neurotrophic factor during establishment
Basic and Applied Pathology, 11/20/09
Treatment of pathologic spinal fractures with combined radiofrequency ablation and balloon kyphoplasty
World Journal of Surgical Oncology, 11/20/09
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
British Journal of Cancer, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


